NCT07099014View on ClinicalTrials.gov

Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

October 13, 2028

Study Completion Date

April 13, 2029

Conditions

Cardiogenic Shock, ECMO

Interventions

DRUG

Inahled Isoflurane

treatment administration

DRUG

Propofol, midazolam

treatment administration

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER